Suppr超能文献

肾细胞癌的预后预测:根据组织学亚型对肿瘤的预后因素进行评估。

Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.

作者信息

Delahunt Brett, Bethwaite Peter B, Nacey John N

机构信息

Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington South, New Zealand.

出版信息

Pathology. 2007 Oct;39(5):459-65. doi: 10.1080/00313020701570061.

Abstract

A wide variety of parameters have been investigated for their prognostic significance in mixed series of renal cell carcinoma (RCC). The classification of RCC into separate types with differing morphology, genotype and probable clinical outcome has led to a re-evaluation of many prognostic parameters with studies confined to a single RCC morphotype. Tumour stage remains the most important predictor of RCC outcome and recent investigations have focused upon tumour diameter and the prognostic significance of stromal, vascular and lymphatic invasion within the renal sinus. In large tumour series, morphotype has been correlated with patient survival, with clear cell RCC being associated with a less favourable outcome than chromophobe RCC and to a lesser extent papillary RCC, for organ confined tumours. The prognostic significance of nuclear grading remains controversial. Fuhrman grading has been shown to have prognostic utility for clear cell RCC in some series. Recent studies have shown that for papillary RCC, grading should be based upon nucleolar size and that Fuhrman grading is inappropriate for chromophobe RCC. Proliferative indices based upon a variety of markers have been correlated with outcome for clear cell RCC (Ki-67, AgNORs, p21(waf1/cip1) and p27(Kip1)) and papillary RCC (Ki-67, AgNORs), although in some series prognostic significance was lost on multivariate analysis. The presence of tumour necrosis has been shown to predict survival for clear cell and chromophobe RCC, and in clear cell RCC quantification of tumour vascular density has been correlated with outcome. Several molecular markers have been investigated for prognostic significance, mostly in clear cell RCC. Although some of these markers have been shown to be significantly associated with survival, these findings remain to be confirmed in large scale follow-up studies.

摘要

在混合性肾细胞癌(RCC)系列研究中,人们对各种各样的参数进行了预后意义的调查。将RCC分为具有不同形态、基因型和可能临床结果的不同类型,导致了对许多预后参数的重新评估,相关研究仅限于单一的RCC形态类型。肿瘤分期仍然是RCC预后最重要的预测指标,最近的研究集中在肿瘤直径以及肾窦内间质、血管和淋巴管侵犯的预后意义上。在大型肿瘤系列研究中,形态类型与患者生存率相关,对于器官局限性肿瘤,透明细胞RCC的预后比嫌色细胞RCC差,在较小程度上也比乳头状RCC差。核分级的预后意义仍存在争议。在一些系列研究中,Fuhrman分级已被证明对透明细胞RCC具有预后价值。最近的研究表明,对于乳头状RCC,分级应基于核仁大小,而Fuhrman分级不适用于嫌色细胞RCC。基于多种标志物的增殖指数已与透明细胞RCC(Ki-67、AgNORs、p21(waf1/cip1)和p27(Kip1))和乳头状RCC(Ki-67、AgNORs)的预后相关,尽管在一些系列研究中,多变量分析显示其预后意义丧失。肿瘤坏死的存在已被证明可预测透明细胞和嫌色细胞RCC的生存率,在透明细胞RCC中,肿瘤血管密度的量化与预后相关。人们对几种分子标志物的预后意义进行了研究,主要是在透明细胞RCC中。尽管其中一些标志物已被证明与生存率显著相关,但这些发现仍有待大规模随访研究的证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验